Double-Dose Firmonertinib Boosts EGFR L858R Lung Cancer Treatment
A groundbreaking advancement in the fight against non-small-cell lung cancer (NSCLC) has emerged from a recent multicenter phase II study ...
Tag: phase II trial
Tislelizumab-Lenvatinib Shows Promise for High-Risk Liver Cancer
In a groundbreaking advance that could redefine the therapeutic landscape for liver cancer, a new single-arm phase II clinical trial ...
POPULAR NEWS
-
Revolutionary AI Model Enhances Precision in Detecting Food Contamination
-
Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them
-
Uncovering Functions of Cavernous Malformation Proteins in Organoids
-
Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy